takeda dedicated to advanced healthcare

Takeda dedicated to advanced healthcare

Global biopharmaceutical company Takeda is committed to supporting Vietnam’s healthcare advancement by bringing life-transforming medicine and vaccines to the population. Benjamin Ping, the new general manager of Takeda Vietnam, talked to VIR’s Tung Anh about his leadership approach to foster innovation and collaboration, ensuring Takeda’s positive and impactful presence in local healthcare.
integrated solutions for dengue fever prevention in vietnam

Integrated solutions for dengue fever prevention in Vietnam

Dengue vaccines being available in Vietnam contributes to strengthening the prevention and control strategy for this infectious disease, but synchronised implementation of multiple solutions is needed to ensure vaccine sustainability.
takedas health innovation and net zero ambition

Takeda’s health innovation and net-zero ambition

Global biopharmaceutical group Takeda, which achieved carbon neutrality in 2020, is committed to its mission of further safeguarding people and the planet, including the development of preventative therapies for infectious diseases - such as its dengue vaccine - which are on the rise due to climate change.
takedas partnerships to deliver innovative medicine and vaccines

Takeda’s partnerships to deliver innovative medicine and vaccines

Global biopharmaceutical company Takeda is deepening collaboration with stakeholders to deliver innovative healthcare solutions in Vietnam, underscoring its commitment to creating sustainable values for the community.
takeda honoured for contributions to vietnams sustainable development

Takeda honoured for contributions to Vietnam's sustainable development

With over a decade of groundbreaking innovative solutions in Vietnam's pharmaceutical sector, Takeda has been recognised for its contribution to sustainable development.
experts discuss dengue fever prevention in vietnam

Experts discuss dengue fever prevention in Vietnam

Takeda, a global biopharmaceutical company, hosted a series of meetings in Ho Chi Minh City and Hanoi on September 26-27 to discuss the essential role of vaccines in an integrated dengue prevention strategy in Vietnam and globally.
takeda delivering transformative healthcare solutions

Takeda delivering transformative healthcare solutions

At the VIR health conference- "Empowering health innovation for sustainability vision" held on September 25, 2024, Dion Warren – area head of India and Southeast Asia (I-SEA) of Takeda, emphasised Takeda's commitment in delivering transformative healthcare solutions for lasting social value.
takedas decade of healthcare commitments in vietnam

Takeda’s decade of healthcare commitments in Vietnam

For over 10 years, Takeda has been a dedicated healthcare partner in Vietnam, delivering transformative treatments and contributing significant value to public health. The recent approval of its dengue vaccine further strengthens this commitment. Dion Warren, Takeda’s area head for India and Southeast Asia, talked to VIR’s Bich Thuy about the company’s journey and its plans to bring more innovative medicines to Vietnam.
takeda dengue vaccine approved in vietnam

Takeda dengue vaccine approved in Vietnam

The Drug Administration of Vietnam (DAV) on May 14 issued a decision approving dengue vaccine of Takeda Pharmaceutical Company Limited, becoming the first dengue vaccine approved in the country for use in individuals from four years of age, regardless of previous dengue exposure and without the need for pre-vaccination testing.
takedas commitment to health equity and access for rare disease community

Takeda's commitment to health equity and access for rare disease community

This year's Rare Disease Day, February 29, served as a momentous occasion to celebrate the extraordinary journeys of rare disease patients and their devoted caregivers. Having established a strong presence in the Vietnamese market over many years, Takeda holds steadfast in its commitment to bolstering the wellbeing of the Vietnamese people, especially those afflicted by rare diseases. Than Trong Son, head of Medical Affairs, Takeda Vietnam, delves into Takeda's tireless endeavours and commitment to supporting patients afflicted by rare diseases in the country.
experts come together to enhance dengue prevention strategies in vietnam

Experts come together to enhance dengue prevention strategies in Vietnam

On September 28, Takeda Pharmaceuticals (Asia-Pacific) Pte., Ltd. (Takeda), in collaboration with The Pasteur Institute in Ho Chi Minh City, held the conference Orientations and Solutions to Enhance Dengue Haemorrhagic Fever Prevention Effectiveness in Vietnam, attracting many top-notch experts from the healthcare industry.
takeda vietnam enhances effectiveness of dengue prevention and control

Takeda Vietnam enhances effectiveness of dengue prevention and control

The Pasteur Institute in Ho Chi Minh City joined hands with Takeda Vietnam to host a workshop on Innovating and enhancing the effectiveness of dengue prevention and control for public health on September 23.
takeda vietnam wins best workplace in asia 2022 award by great place to work

Takeda Vietnam wins Best Workplace in Asia 2022 award by Great Place to Work

Takeda Vietnam has prevailed over thousands of organisations to win the Best Workplace in Asia 2022 award by Great Place to Work, the global authority on workplace culture.
takeda vietnam listed in the inaugural 2022 vietnam best workplaces

Takeda Vietnam listed in the inaugural 2022 Vietnam Best Workplaces

Takeda Vietnam was recognised as one of Vietnam’s best workplaces in 2022 by Great Place to Work® ASEAN & ANZ, the global organisation on workplace culture.
takeda vietnam and gaia plant over 500 trees in can gio biosphere reserve

Takeda Vietnam and Gaia plant over 500 trees in Can Gio Biosphere Reserve

Takeda Vietnam is demonstrating its commitment to protecting the planet through the planting of more than 500 trees in Can Gio Biosphere Reserve, located about 50km from Ho Chi Minh City.
EMC Đã kết nối EMC